Literature DB >> 16125886

New drug salt formation in biodegradable microspheres.

Ahmad Al-Maaieh1, Douglas R Flanagan.   

Abstract

PURPOSE: To investigate the effects of inorganic salts in the external phase of an oil-in-water (O/W) emulsion method during microsphere preparation.
METHODS: An O/W emulsion method was used to prepare poly(D,L-lactic acid) microspheres containing quinidine sulfate. Different inorganic salts were used in the external phase during microsphere preparation. Microsphere drug loading was determined by UV and the drug salt anions inside the microspheres were determined by ion chromatography.
RESULTS: New drug salts were formed during encapsulation in the microspheres when salts with non-common anions to the drug salt were used. Drug loading increased when NaClO4 or NaSCN were used. The fraction of drug as the new salt in microspheres increased non-linearly with the salt concentration in the external phase, however, the fraction of drug as the new encapsulated salt was linearly related to drug loading. Drug loading decreased and new salt fraction increased with increasing organic solvent volume or with decreasing cosolvent polarity.
CONCLUSIONS: Introducing salts containing non-common anions to the drug salt employed in the external phase of O/W emulsion microsphere method leads to new salt formation. The extent of new drug salt formation is affected by salt levels added, cosolvent type and polymer concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125886     DOI: 10.1016/j.ijpharm.2005.06.029

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

2.  Alternating release of different bioactive molecules from a complexation polymer system.

Authors:  Ju Hyeong Jeon; David A Puleo
Journal:  Biomaterials       Date:  2008-06-02       Impact factor: 12.479

3.  Formulation optimization of propranolol hydrochloride microcapsules employing central composite design.

Authors:  H N Shivakumar; R Patel; B G Desai
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.